RELATING TO HEALTH.
Summary
Prohibits the sale of nonprescription diet pills and dietary supplements for weight loss or muscle building to any person under eighteen years of age. Requires retail establishments and delivery sellers to follow certain protocols regarding certain products to prevent access by minors to the restricted products. Effective 1/30/2050. (SD1)
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2026
Committee Review
Feb 2026
Senate Passage
Feb 2026
House Passage
Governor
Introduced Jan 14, 2026
Last action Feb 26, 2026
Maddy AI version diff · 1 comparison
What changed between versions
SB2106
→
SB2106_SD1
·
4 edits
MODERATE
This bill amends Hawaii law to prohibit the sale of nonprescription diet pills and dietary supplements for weight loss or muscle building to anyone under eighteen years of age. It updates the definition of these products to focus on labeling and representation rather than marketing methods, and it changes the effective date of the law from immediate approval to January 30, 2050.
Scope change
The bill's scope remains focused on restricting access to specific dietary products for minors, but the criteria for identifying these products were narrowed to exclude 'marketing' from the definition.
REQUIREMENT
The requirement for delivery sellers to use specific shipping methods was updated to apply to products labeled or represented for weight loss or muscle building, removing the explicit reference to 'marketing' in the definition of these products.
DEFINITION
The definition of 'Dietary supplement for weight loss or muscle building' was changed to rely solely on whether the product is labeled or represented for these purposes, rather than also considering how it is marketed.
The definition of 'Nonprescription diet pill' was similarly updated to rely on labeling and representation rather than marketing.
TIMELINE
The effective date of the Act was changed from 'upon approval' to a fixed future date of January 30, 2050.
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
9
Key actions
4
Committee
5
Feb 20, 2026
Upper · Passed
The committee(s) on CPN will hold a public decision making on 02-26-26 9:45AM; Conference Room 229 & Videoconference.
upper
Feb 11, 2026
Upper · Passed
Report adopted; Passed Second Reading, as amended (SD 1) and referred to CPN.
upper
Feb 11, 2026
Committee
Reported from HHS (Stand. Com. Rep. No. 2197) with recommendation of passage on Second Reading, as amended (SD 1) and referral to CPN.
upper
Feb 2, 2026
Upper · Passed
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: Senator(s) McKelvey ; 0 No(es): none; and 0 Excused: none.
upper
Jan 30, 2026
Upper · Passed
The committee(s) on HHS has scheduled a public hearing on 02-02-26 1:05PM; Conference Room 225 & Videoconference.
upper
Jan 22, 2026
Committee
Referred to HHS, CPN.
upper
Jan 21, 2026
Introduced
Introduced and passed First Reading.
upper
Jan 14, 2026
Introduced
Pending Introduction.
upper
3 primary · 2 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 2106
Scope: HI
Hi! I can help you understand SB 2106. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline